According to newly revealed details, China has been uncovered of subsidizing the manufacturing and exporting of illicit fentanyl precursor chemicals and synthetic narcotics. These details have been released by the House Select Committee on the Chinese Communist Party, shedding new light on the extensive role China plays in the global illicit drug trade.

The 64-page report published by the committee highlights the alarming fact that China’s subsidization encourages international synthetic drug sales and remains undisclosed to the Chinese public. The investigation, led by Chairman Mike Gallagher and Ranking Member Raja Krishnamoorthi, uncovered several other important details regarding China’s involvement in the fentanyl epidemic, painting a damning picture of China’s complicity.

Beyond Subsidies: A Multifarious Web of Complicity

In addition to subsidization, the report reveals that the Chinese Communist Party holds ownership interest in various Chinese companies involved in drug trafficking, thereby impeding U.S.-led investigations into manufacturers of fentanyl precursors. The Chinese government’s control also extends to the censorship of online content related to narcotics, except for those narcotics set to be exported.

The shocking findings outlined in the report have far-reaching implications. They illustrate how China’s actions and omissions violate global laws, leading to unimaginable suffering for countless individuals in the United States and worldwide. In reaping strategic and economic benefits, the Chinese Communist Party willfully disregards the profound human toll caused by the fentanyl crisis.

A Rigorous Investigation and a Blow to Formal Acknowledgment

The conclusions drawn by the committee have been reached after extensive examination of Chinese websites, government documents, and undercover communications with drug trafficking organizations based in China. The committee’s findings undermine the Chinese government’s public acknowledgment that the trafficking of fentanyl precursors and narcotics materials is illegal within China.

Moreover, the report challenges the effectiveness of previous agreements to combat fentanyl trafficking. The coordination efforts of both President Joe Biden and Chinese President Xi Jinping, including their recent discussions, are called into question after these latest revelations.

A Looming Crisis and Urgent Recommendations

As fentanyl overdose deaths in the U.S. continue to skyrocket, urgent actions are needed to address the crisis. The House committee recommends the establishment of a joint task force to counter the fentanyl epidemic. Furthermore, stronger sanctions on Chinese entities involved in the fentanyl trade must be imposed, alongside other preventive measures.

Testimonies from Respected Individuals Strengthen the Despite Disturbing Picture

Former U.S. Attorney General Bill Barr, while testifying before the congressional panel, hailed the groundbreaking nature of the report and emphasized the evidential linkages between the People’s Republic of China and the Chinese Communist Party. Recognizing the active sponsorship, encouragement, and facilitation of fentanyl production and export, Barr shed further light on the complicity of the Chinese Communist Party.

Alongside Barr’s testimony, insights from former DEA chief of operations Ray Donovan and RAND Corporation senior international and defense researcher David Luckey contributed to a comprehensive understanding of the dire situation.

The findings are a wake-up call, demanding swift international action to confront and curb China’s role in the fentanyl epidemic. As the leading cause of death among Americans ages 18-45, the lethal impact of fentanyl necessitates a united front in the face of this multifaceted crisis.